Public Company News

iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products inChina, today announced its unaudited financial results for the third quarter endedSeptember 30, 2025. Third Quarter 2025 Highlights...

2025-12-29 17:11 7218

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech has responded by building an integrated pharmacology pl...

2025-12-29 14:13 3097

XPENG-Peking University Collaborative Research Accepted by AAAI 2026: Introducing a Novel Visual Token Pruning Framework for Autonomous Driving

* XPENG-PKU Research Breakthrough: XPENG, in collaboration with Peking University, has developed FastDriveVLA—a novel visualtoken pruning framework that enables autonomous driving AI to "drive like a human" by focusing only on essential information, achieving a 7.5x reduction in computational l...

2025-12-29 13:35 4852

JinkoSolar Announces Results of 2025 Annual General Meeting

SHANGRAO, China, Dec. 29, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that all shareholders resolutions proposed at the Company's 2025 annual general ...

2025-12-29 13:13 3802

Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC "Blockbuster" Therapy

TAIPEI and SAN DIEGO, Dec. 28, 2025 /PRNewswire/ -- Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging field of cold tumor treatment, Senhwa Biosciences, Inc. ...

2025-12-29 10:24 2763

Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Dec. 28, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that it has entered into a l...

2025-12-29 09:58 3519

CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

SHANGHAI, Dec. 28, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that it has submitted two separate Investigational New Drug (IND) applications to the National Medical Products Administr...

2025-12-29 08:10 3077

LG Display showcases wide lineup of world-first, leading OLED monitors

SEOUL, South Korea, Dec. 27, 2025 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, is set to rewrite industry records once again at CES 2026, the world's largest IT and consumer electronics exhibition.

2025-12-28 09:00 2149

NetEase Announces Management Change

HANGZHOU, China, Dec. 26, 2025 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that after 23 years with the Company,Yingfeng Ding has decided to retire from his position as Executive Vice Presi...

2025-12-27 05:15 2106

TGE Executes SPA for New York Tribeca Hotel Successfully

PARIS and NEW YORK and LONDON, Dec. 26, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., announce jointly that TGEhas exec...

2025-12-26 23:58 7161

LEIFRAS Co., Ltd. to Launch Collaborative Project Addressing School Refusal

Leifras Co., Ltd., Tachibana Gakuen Educational Corporation, and Matsumoto Co., Ltd. Enter into a Memorandum of Understanding TOKYO, Dec. 26, 2025 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and comm...

2025-12-26 17:00 2333

Leifras Notice regarding the conclusion of a commitment line agreement totaling 2.5 billion yen to diversify fund-raising channels and strengthen the financial base

TOKYO, Dec. 25, 2025 /PRNewswire/ -- Leifras Co., Ltd. (NASDAQ: LFS, Head Office: Shibuya-ku,Tokyo, Representative Director: Kiyotaka Ito, hereinafter referred to as "the Company"), which operates sports schools for children and supports the local expansion of club activities, is pleased to annou...

2025-12-25 22:00 6070

Tuya Smart Launches "Hey Tuya:" A Super AI Life Assistant Bringing Physical AI to Everyday Life

* Is the real-life J.A.R.V.I.S AI assistant from Marvel's Iron Man movies almost here? HANGZHOU, China, Dec. 25, 2025 /PRNewswire/ -- Tuya Smart (NYSE: TUYA; HKEX: 2391), a global AI cloud platform service provider, today announced the launch of Hey Tuya, a next-generation Super AI Life Assista...

2025-12-25 17:18 3131

China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval

* TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite instability-high or mismatch repair deficient (MSI-H/dMMR) colon cancer. * The TABOSUN® and TYVYT® c...

2025-12-25 16:45 3534

Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies

* Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management (CBL-0201WR Phase 2). * The study will evaluate CBL-514 in combination with Zepbound® (Eli Lilly) in...

2025-12-25 10:05 1874

Co-PSMA abstract accepted for oral presentation at EAU Annual Congress 2026

SYDNEY, Dec. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the acceptance of an ...

2025-12-24 22:02 3239

Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study

SHANGHAI, Dec. 24, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance from the U.S. Food and Drug Administration (FDA) for its self-developed anti-ST2 monoclonal antibody (R&...

2025-12-24 22:00 3146

Eastern International Ltd. Entered into Contract for its First Photovoltaic Power Generation Construction Project With a Total Contract Price of RMB 42.5 Million (approximately US$ 6.04 million)

HANGZHOU, China, Dec. 24, 2025 /PRNewswire/ -- Eastern International Ltd. ("Eastern International" or the "Company") (NASDAQ: ELOG), a provider of domestic and cross-border professional logistic services including project logistic and general logistic for Company clients, today announced that its...

2025-12-24 21:30 7044

AMTD Digital's Subsidiary TGE Successfully Executed Multiple SPAs for Hotel Acquisitions to Add USD 300 million Worth of Assets

PARIS and NEW YORK and LONDON, Dec. 24, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., announce jointly the successful e...

2025-12-24 20:58 5699

Canadian Solar Appoints Colin Parkin as President and Dylan Marx as Chief Operating Officer

KITCHENER, ON, Dec. 24, 2025 /PRNewswire/ -- Canadian Solar Inc . (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced the appointment of Colin Parkin as a member of its Board of Directors and his promotion to President of Canadian Solar. Parkin succe...

2025-12-24 20:00 3054
1 ... 19202122232425 ... 775